ReviewInfection and drug resistance2025

Efficacy of Lefamulin for Community-Acquired Bacterial Pneumonia (CABP) Patients: Pooled Analysis of the Lefamulin Evaluation Against Pneumonia (LEAP) 1, LEAP 2 and LEAP China Trials.

Shuo Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.